AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (February 23, 2007). doi:10.1152/ajpheart.00783.2006
This Article
Right arrow Full Text (PDF)
Right arrow Expanded Material and Methods
Right arrow All Versions of this Article:
293/1/H142    most recent
00783.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, S.
Right arrow Articles by Zeldin, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, S.
Right arrow Articles by Zeldin, D. C.
Submitted on July 21, 2006
Accepted on February 22, 2007

Cytochrome P450 Epoxygenases Protect Endothelial Cells from Apoptosis Induced by Tumor Necrosis Factor-{alpha} via MAPK and PI3K/Akt Signaling Pathways

Shilin Yang1, Li Lin1, Ji-Xiong Chen2, Craig R. Lee3, John M. Seubert4, Yan Wang2, Hong Wang2, Zhong-Ren Chao5, De-Ding Tao6, Jian-Ping Gong7, Zai-Ying Lu6, Dao Wen Wang1*, and Darryl C. Zeldin8

1 Institute of Hypertension, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
2 Wuhan, China; Institute of Hypertension, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
3 Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, United States
4 Research Triangle Park, North Carolina, United States; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, United States
5 Life Science College of Beijing University, Beijing, China
6 Wuhan, China; Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
7 Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
8 Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States

* To whom correspondence should be addressed. E-mail: dwwang{at}tjh.tjmu.edu.cn.

Endothelial cells play a vital role in the maintenance of cardiovascular homeostasis. Epoxyeicosatrienoic acids (EETs), cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acid in endothelial cells, possess potent and diverse biological effects within the vasculature. We evaluated the effects of overexpression of CYP epoxygenases on tumor necrosis factor (TNF)-{alpha} induced apoptosis in bovine aortic endothelial cells (BAECs). CYP epoxygenase overexpression, which is known to increase EET biosynthesis, significantly increased endothelial cell viability and inhibited TNF-{alpha} induction of endothelial cell apoptosis as evaluated by morphological analysis of nuclear condensation, DNA laddering and FACS analysis. CYP epoxygenase overexpression also significantly inhibited caspase-3 activity and downregulation of Bcl-2 expression induced by TNF-{alpha}. The anti-apoptotic effects of CYP epoxygenase overexpression were significantly attenuated by inhibition of the PI3K/Akt and MAPK signaling pathways; however, inhibition of endothelial nitric oxide synthase activity had no effect. Furthermore, CYP epoxygenase overexpression significantly attenuated the extent of TNF-{alpha} induced ERK1/2 dephosphorylation in a time-dependent manner, and significantly increased PI3K expression and Akt phosphorylation in both the presence and absence of TNF-{alpha}. Collectively, these results suggest that CYP epoxygenase overexpression and the concomitant increase in EET biosynthesis significantly protects endothelial cells from apoptosis induced by TNF-{alpha}. This effect is mediated, at least in part, through inhibition of ERK dephosphorylation and activation of PI3K/Akt signaling.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. J. Gross, K. M. Gauthier, J. Moore, J. R. Falck, B. D. Hammock, W. B. Campbell, and K. Nithipatikom
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2838 - H2844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Dhanasekaran, S. K. Gruenloh, J. N. Buonaccorsi, R. Zhang, G. J. Gross, J. R. Falck, P. K. Patel, E. R. Jacobs, and M. Medhora
Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H724 - H735.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.